Pushing the Boundaries in CLD | Webinar 2
The Physics and Technology Underlying the Beacon Platform for Cell Line Development
Overview
This session will take a deep dive into the core technology powering the Beaconยฎ platform and its impact on cell line development. We will explore how Optoelectronic Positioning (OEP) technology, AI-based cellular detection, and microfluidic NanoPenยฎ chambers work together to enhance high-precision clone selectionโultimately compressing timelines while improving productivity and quality.
Attendees will gain an understanding of how the Beacon system mimic bioreactor-like conditions and enables multiple sequential assays to assess productivity, stability, and quality attributes with complete automated workflowsโall while maintaining FDA-validated monoclonality standards.
Speakers
Or Gadish, Ph.D.
Senior Manager, Applications Research and Development Engineering, Bruker Cellular Analysis
Or Gadish has been instrumental in developing automated assays on the Beaconยฎ platform, including the Bispecific Heterodimer Assay and the OptoSeq 3' mRNA Assay. His background in biomedical engineering focuses on high-throughput functional assays for cellular analysis.
Eric Sackmann, Ph.D.
Director of Product Management, Bruker Cellular Analysis
Eric Sackmann led the development of the Optoยฎ Cell Line Development workflow on the Beaconยฎ platform. His expertise lies in microfluidics, immunology, and biopharmaceutical automation.
Live Webcast Details
Key Takeaways
- Compress Cell Line Development Timelines: How the Beacon platform reduces timelines while selecting more productive clones.
- Advanced Clone Selection: Best in class assays to ensure high-performing clone selection.
- Confidently Submit IND Filings to Regulators: How the system delivers superior end to end monoclonality assurance.